GALENICA S A has a total of 20 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2016. It filed its patents most often in China, EPO (European Patent Office) and Hungary. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GUANGZHOU CELLPROTEK PHARMACEUTICAL CO LTD, ISHIKAWA MAKOTO and BARR LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Hungary | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Serbia | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Canada | 1 | |
#9 | United Kingdom | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | Mexico | 1 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Trafalis Dimitrios | 17 |
#2 | Dimitrios Trafalis | 1 |
Publication | Filing date | Title |
---|---|---|
GB202002141D0 | Compounds | |
CA3030493A1 | New 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives | |
CN107835817A | The ester of steroidal lactams and double (2 chloroethyl) amino-benzene oxygen propanoic derivatives |